{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:46:52Z","timestamp":1787028412517,"version":"build-2736575974"},"reference-count":74,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fonds voor Wetenschappelijk Onderzoek-Vlaanderen","award":["OT\/13\/090"],"award-info":[{"award-number":["OT\/13\/090"]}]},{"name":"Fonds voor Wetenschappelijk Onderzoek-Vlaanderen","award":["G0A3114N"],"award-info":[{"award-number":["G0A3114N"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The risk of heart failure (HF) is prominently increased in patients with type 2 diabetes mellitus. The objectives of this study were to establish a murine model of diabetic cardiomyopathy induced by feeding a high-sugar\/high-fat (HSHF) diet and to evaluate the effect of reconstituted HDLMilano administration on established HF in this model. The HSHF diet was initiated at the age of 12 weeks and continued for 16 weeks. To investigate the effect of reconstituted HDLMilano on HF, eight intraperitoneal administrations of MDCO-216 (100 mg\/kg protein concentration) or of an identical volume of control buffer were executed with a 48-h interval starting at the age of 28 weeks. The HSHF diet-induced obesity, hyperinsulinemia, and type 2 diabetes mellitus. Diabetic cardiomyopathy was present in HSHF diet mice as evidenced by cardiac hypertrophy, increased interstitial and perivascular fibrosis, and decreased myocardial capillary density. Pressure-volume loop analysis indicated the presence of both systolic and diastolic dysfunction and of decreased cardiac output in HSHF diet mice. Treatment with MDCO-216 reversed pathological remodelling and cardiac dysfunction and normalized wet lung weight, indicating effective treatment of HF. No effect of control buffer injection was observed. In conclusion, reconstituted HDLMilano reverses HF in type 2 diabetic mice.<\/jats:p>","DOI":"10.3390\/ijms20061273","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T04:15:29Z","timestamp":1552536929000},"page":"1273","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8186-6620","authenticated-orcid":false,"given":"Joseph Pierre","family":"Aboumsallem","sequence":"first","affiliation":[{"name":"Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-7672","authenticated-orcid":false,"given":"Ilayaraja","family":"Muthuramu","sequence":"additional","affiliation":[{"name":"Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0918","authenticated-orcid":false,"given":"Mudit","family":"Mishra","sequence":"additional","affiliation":[{"name":"Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9915-5322","authenticated-orcid":false,"given":"Herman","family":"Kempen","sequence":"additional","affiliation":[{"name":"The Medicines Company (Schweiz) GmbH, CH-8001 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-686X","authenticated-orcid":false,"given":"Bart","family":"De Geest","sequence":"additional","affiliation":[{"name":"Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Catholic University of Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members, Ryden, L., Grant, P.J., Anker, S.D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., and Hammes, H.P. (2013). ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur. Heart J., 34, 3035\u20133087.","DOI":"10.1093\/eurheartj\/eht108"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/dc12-0474","article-title":"Right ventricular involvement in diabetic cardiomyopathy","volume":"36","author":"Widya","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ar.23052","article-title":"Morphological restructuring of myocardium during the early phase of experimental diabetes mellitus","volume":"298","author":"Danilova","year":"2015","journal-title":"Anat. Rec."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Bmj"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/JOE-16-0679","article-title":"Insulin receptor substrate signaling controls cardiac energy metabolism and heart failure","volume":"233","author":"Guo","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-016-0309-5","article-title":"PPARs modulate cardiac metabolism and mitochondrial function in diabetes","volume":"24","author":"Lee","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: Molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","article-title":"CD36 deficiency rescues lipotoxic cardiomyopathy","volume":"100","author":"Yang","year":"2007","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.107.689935","article-title":"Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community","volume":"116","author":"Dhingra","year":"2007","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/dc10-1079","article-title":"Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: A meta-analysis","volume":"33","author":"Malik","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.mayocp.2014.12.019","article-title":"Added fructose: A principal driver of type 2 diabetes mellitus and its consequences","volume":"90","author":"DiNicolantonio","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1228S","DOI":"10.3945\/jn.108.098277","article-title":"National estimates of dietary fructose intake increased from 1977 to 2004 in the United States","volume":"139","author":"Marriott","year":"2009","journal-title":"J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/ncomms3434","article-title":"Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome","volume":"4","author":"Lanaspa","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/502181a","article-title":"Metabolic syndrome: F stands for fructose and fat","volume":"502","author":"Lyssiotis","year":"2013","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.26594","article-title":"High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase","volume":"58","author":"Ishimoto","year":"2013","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"The proteomic diversity of high density lipoproteins: Our emerging understanding of its importance in lipid transport and beyond","volume":"54","author":"Shah","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/1566524013666131118113927","article-title":"Pleiotropic effects of HDL: Towards new therapeutic areas for HDL-targeted interventions","volume":"14","author":"Gordts","year":"2014","journal-title":"Curr. Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14712598.2017.1333597","article-title":"New perspectives on biological HDL-targeted therapies","volume":"17","author":"Muthuramu","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/978-3-319-09665-0_17","article-title":"Therapeutic potential of HDL in cardioprotection and tissue repair","volume":"224","author":"Frias","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.107.710830","article-title":"Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy","volume":"117","author":"Spillmann","year":"2008","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gordts, S.C., Van Craeyveld, E., Muthuramu, I., Singh, N., Jacobs, F., and De Geest, B. (2012). Lipid Lowering and HDL Raising Gene Transfer Increase Endothelial Progenitor Cells, Enhance Myocardial Vascularity, and Improve Diastolic Function. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046849"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Amin, R., Muthuramu, I., Aboumsallem, J.P., Mishra, M., Jacobs, F., and De Geest, B. (2017). Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18092012"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI109956","article-title":"A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family","volume":"66","author":"Franceschini","year":"1980","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1172\/JCI109957","article-title":"A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins","volume":"66","author":"Weisgraber","year":"1980","journal-title":"J. Clin. Investig."},{"key":"ref_27","first-page":"1083","article-title":"AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission","volume":"37","author":"Gualandri","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: The Limone sul Garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjcvp\/pvv041","article-title":"A single infusion of MDCO-216 (ApoA-1 Milano\/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease","volume":"2","author":"Kallend","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","journal-title":"Curr. Diabetes Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1043-2760(97)00094-5","article-title":"How obesity causes diabetes in Zucker diabetic fatty rats","volume":"8","author":"Unger","year":"1997","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/en.2013-1256","article-title":"Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet","volume":"154","author":"Manrique","year":"2013","journal-title":"Endocrinology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.108.118919","article-title":"Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor","volume":"53","author":"Spillmann","year":"2009","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbrc.2010.11.037","article-title":"High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy","volume":"404","author":"Lin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/jcmm.12567","article-title":"High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K\/Akt pathway","volume":"19","author":"Lin","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mishra, M., Muthuramu, I., Aboumsallem, J.P., Kempen, H., and De Geest, B. (2018). Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113399"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/01.ATV.0000216600.37436.cf","article-title":"High-density lipoproteins enhance progenitor-mediated endothelium repair in mice","volume":"26","author":"Tso","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00109-008-0427-y","article-title":"Wild-type apo A-I and apo A-I(Milano) gene transfer reduce native and transplant arteriosclerosis to a similar extent","volume":"87","author":"Feng","year":"2009","journal-title":"J. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood-2008-06-161794","article-title":"Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer","volume":"113","author":"Feng","year":"2009","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/ATVBAHA.107.158741","article-title":"Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells","volume":"28","author":"Feng","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12950-016-0131-6","article-title":"Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob\/ob mice","volume":"13","author":"Spillmann","year":"2016","journal-title":"J. Inflamm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/ATVBAHA.115.305887","article-title":"High-Density Lipoproteins Reduce Endothelial-to-Mesenchymal Transition","volume":"35","author":"Spillmann","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-319-09665-0_6","article-title":"Signal transduction by HDL: Agonists, receptors, and signaling cascades","volume":"224","author":"Nofer","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12551-014-0159-x","article-title":"Microdomain-specific localization of functional ion channels in cardiomyocytes: An emerging concept of local regulation and remodelling","volume":"7","author":"Balycheva","year":"2015","journal-title":"Biophys. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jacc.2010.11.072","article-title":"Reconstituted high-density lipoprotein shortens cardiac repolarization","volume":"58","author":"Franssen","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cvr\/cvp024","article-title":"Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1\/2: Role of sphingosine-1-phosphate","volume":"82","author":"Frias","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/ATVBAHA.118.310946","article-title":"Hepatocyte-Specific SR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1-Deficient Mice and Improves Pressure Overload-Induced Cardiomyopathy","volume":"38","author":"Muthuramu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cardiores.2005.08.014","article-title":"Autophagy in cardiac myocyte homeostasis, aging, and pathology","volume":"68","author":"Terman","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.yjmcc.2011.06.010","article-title":"Autophagy as a therapeutic target in cardiovascular disease","volume":"51","author":"Nemchenko","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.yjmcc.2011.03.002","article-title":"Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice","volume":"50","author":"Mellor","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.atherosclerosis.2010.01.001","article-title":"Impact of HDL on adipose tissue metabolism and adiponectin expression","volume":"210","author":"Spillmann","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00125-007-0752-7","article-title":"Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism","volume":"50","author":"Han","year":"2007","journal-title":"Diabetologia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/cc10021","article-title":"Clinical review: Adiponectin biology and its role in inflammation and critical illness","volume":"15","author":"Robinson","year":"2011","journal-title":"Crit. Care"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardiores.2006.10.009","article-title":"Adiponectin actions in the cardiovascular system","volume":"74","author":"Hopkins","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1152\/ajpendo.00110.2003","article-title":"Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans","volume":"285","author":"Bruun","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/diabetes.52.7.1779","article-title":"Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression","volume":"52","author":"Kern","year":"2003","journal-title":"Diabetes"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","article-title":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome","volume":"314","author":"Maury","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation\u2014Cause or Consequence of Heart Failure or Both?","volume":"14","author":"Tschope","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11886-018-1067-7","article-title":"Tumor Necrosis Factor-alpha in Heart Failure: An Updated Review","volume":"20","author":"Schumacher","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: The cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1111\/bph.14463","article-title":"Successful treatment of established heart failure in mice with recombinant HDL (Milano)","volume":"175","author":"Aboumsallem","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/bit.22542","article-title":"Integrated solution to purification challenges in the manufacture of a soluble recombinant protein in E. coli","volume":"105","author":"Caparon","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.M033779","article-title":"Effect of repeated apoA-IMilano\/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys","volume":"54","author":"Kempen","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Muthuramu, I., Amin, R., Postnov, A., Mishra, M., Jacobs, F., Gheysens, O., Van Veldhoven, P.P., and De Geest, B. (2017). Coconut Oil Aggravates Pressure Overload-Induced Cardiomyopathy without Inducing Obesity, Systemic Insulin Resistance, or Cardiac Steatosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071565"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00109-015-1281-3","article-title":"Selective homocysteine-lowering gene transfer attenuates pressure overload-induced cardiomyopathy via reduced oxidative stress","volume":"93","author":"Muthuramu","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.ymthe.2017.07.017","article-title":"Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice","volume":"25","author":"Muthuramu","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01002772","article-title":"Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections","volume":"11","author":"Junqueira","year":"1979","journal-title":"Histochem. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI40096","article-title":"Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents","volume":"120","author":"Shimizu","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/gt.2011.147","article-title":"Low-density lipoprotein receptor gene transfer in hypercholesterolemic mice improves cardiac function after myocardial infarction","volume":"19","author":"Jacobs","year":"2012","journal-title":"Gene Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/gt.2013.30","article-title":"Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice","volume":"20","author":"Gordts","year":"2013","journal-title":"Gene Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s003950200013","article-title":"Progressive heart failure after myocardial infarction in mice","volume":"97","author":"Bayat","year":"2002","journal-title":"Basic Res. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/6\/1273\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:38:38Z","timestamp":1760186318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/6\/1273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":74,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijms20061273"],"URL":"https:\/\/doi.org\/10.3390\/ijms20061273","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]}}}